NSC7524
| dc.creator | US National Cancer Institute | en_GB |
| dc.date.accessioned | 2004-12-13T14:38:23Z | |
| dc.date.available | 2004-12-13T14:38:23Z | |
| dc.date.created | 2003-02-01 | en_GB |
| dc.date.issued | 2004-12-13T14:38:23Z | |
| dc.format.extent | 14943 bytes | |
| dc.format.extent | 12058 bytes | |
| dc.format.mimetype | chemical/x-cml | |
| dc.format.mimetype | chemical/x-cml | |
| dc.identifier | NSC7524 | en_GB |
| dc.identifier.ichi | C36H51NO11,1H3-23H-9H2-12H2-27H-31(3H3,40H)35(43H)26H(17H2-37(27)16H2-23)33(42H)18H2-34-25H(32(33,41H)15H2-28H(35)39H)11H2-10H2-24H-30(34,2H3)14H2-13H2-29H(36(24,44H)48-34)47-22(38)19-6H-7H-20(45-4H3)21(8H-19)46-5H3 | en_GB |
| dc.identifier.inchi | InChI=1S/C36H51NO11/c1-19-6-11-26-31(3,40)35(43)25(17-37(26)16-19)33(42)18-34-24(32(33,41)15-27(35)38)10-9-23-30(34,2)13-12-28(36(23,44)48-34)47-29(39)20-7-8-21(45-4)22(14-20)46-5/h7-8,14,19,23-28,38,40-44H,6,9-13,15-18H2,1-5H3/t19-,23-,24-,25-,26-,27-,28-,30-,31+,32+,33+,34+,35-,36-/m0/s1 | |
| dc.identifier.inchikey | FVECELJHCSPHKY-YFUMOZOISA-N | |
| dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/8776 | |
| dc.language.iso | en_GB | |
| dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
| dc.title | NSC7524 | en_GB |
| dc.title.alternative | Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(3, 4-dimethoxybenzoate), (3.beta.,4.alpha.,16.beta.)- (9CI) | en_GB |
| dc.title.alternative | Veratridine | en_GB |
| dc.title.alternative | Veratrine | en_GB |
| dc.title.alternative | Veratrine (amorphous) (VAN) | en_GB |
| dc.title.alternative | VERATRIDINE | en_GB |
| dc.title.alternative | WLN: T J6 H6 E6 D5665/TC& 3ATU C& ON TX C&OTJ EQ GQ HQ IQ I1 M1 RQ U1 A&OVR CO1 DO1& B&Q | en_GB |
| dc.title.alternative | 3-Veratroylveracevine | en_GB |
| dc.title.alternative | 4, 9-Epoxycevane-3,4,12,14,16,17,20-heptol 3-(3,4-dimethoxybenzoate) | en_GB |
| dc.type | Chemical Structures | en_GB |